These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6341244)

  • 1. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.
    O'Brien AD; LaVeck GD
    Infect Immun; 1983 May; 40(2):675-83. PubMed ID: 6341244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
    Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
    Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK
    Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
    MacLeod DL; Gyles CL
    Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.
    O'Brien AD; LaVeck GD; Griffin DE; Thompson MR
    Infect Immun; 1980 Oct; 30(1):170-9. PubMed ID: 7002787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of heat-labile enterotoxin from four Escherichia coli strains by affinity immunoadsorbent: evidence for similar subunit structure.
    Dafni Z; Sack RB; Craig JP
    Infect Immun; 1978 Dec; 22(3):852-60. PubMed ID: 103838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.
    Ashkenazi S; Cleary TG
    J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on shiga-like toxin produced by enterohemorrhagic Escherichia coli: purification and characterization of the toxin and development of methods for identifying the toxin.
    Kongmuang U
    Med J Osaka Univ; 1989 Mar; 38(1-4):39-49. PubMed ID: 2485395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Shiga-like toxin in Escherichia coli strains, etiological agents of diarrheal disease.
    Meitert T; Tonciu M; Ciudin L; Pencu E; Mihai I; Nicolescu S
    Arch Roum Pathol Exp Microbiol; 1989; 48(4):293-8. PubMed ID: 2520669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and chemical characterization of the heat-labile enterotoxin produced by enterotoxigenic Escherichia coli.
    Kunkel SL; Robertson DC
    Infect Immun; 1979 Aug; 25(2):586-96. PubMed ID: 39893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin.
    Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 Jul; 3(1):21-30. PubMed ID: 3143036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography.
    Ryd M; Alfredsson H; Blomberg L; Andersson A; Lindberg AA
    FEBS Lett; 1989 Dec; 258(2):320-2. PubMed ID: 2689221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.
    O'Brien AD; LaVeck GD; Thompson MR; Formal SB
    J Infect Dis; 1982 Dec; 146(6):763-9. PubMed ID: 6754826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subunit structure of Shigella cytotoxin.
    Olsnes S; Reisbig R; Eiklid K
    J Biol Chem; 1981 Aug; 256(16):8732-8. PubMed ID: 7021550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical characterization of A and B subunits of Shiga toxin and reconstitution of holotoxin from isolated subunits.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1987; 31(3):189-97. PubMed ID: 3302622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and physicochemical properties of a unique Vero cell cytotoxin from Escherichia coli O157:H7.
    Padhye VV; Kittell FB; Doyle MP
    Biochem Biophys Res Commun; 1986 Sep; 139(2):424-30. PubMed ID: 3533062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
    Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
    Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.
    Strockbine NA; Marques LR; Holmes RK; O'Brien AD
    Infect Immun; 1985 Dec; 50(3):695-700. PubMed ID: 3905611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.